MedPath

Step by Step Group Therapy for Bulimia Nervosa: Effectiveness and Mechanisms of Change.

Not Applicable
Recruiting
Conditions
Bulimia Nervosa
Interventions
Behavioral: l Group Therapy for BN.
Registration Number
NCT06063278
Lead Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Brief Summary

This a pseudo-randomized clinical trial that examines if a specific group therapy for BN is effective in improving its symptomatology, and what variables mediate such improvements. To do so a sample of 100 patients with BN will be pseudorandomized in a Group Therapy for BN or in a control waiting list group. Patients will be assessed at baseline, at the end of the group therapy and at 2 year follow up.

Detailed Description

This is a controlled non randomized study that will compare a group of patients with BN that participate in the SBS group therapy with a group of BN patients who will be in wait list as a control condition.

Patients for this single center trial will be recruited from the outpatient facility of the Hospital de la Santa Creu I Sant Pau (Barcelona, Spain).

After assessed for eligibility participants will be given a set of self -report questionnaires. After the questionnaires are completed participants will be allocated to wait list condition or to the treatment arm. Time between assessment and starting the SBS group will be a month or least. Participants will be administered the same questionnaires the following month after finishing the treatment or after 3 to 4 months after the first assessment for the control condition.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Diagnostic of Bulimia Nervosa
Exclusion Criteria
  • Not understanding Spanish or Catalan Language

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BN Groupl Group Therapy for BN.Patients will take part of a Therapeutic BN Group
Primary Outcome Measures
NameTimeMethod
Eating Attitudes Test, E-40.3 months

A self report questionarie that assesses eating disorder symptomatology. The range of scores is 0-78. Higher scores mean higher eating disorders sympthoms.

Bulimic Investigatory Test Edinburgh, BITE3 months

A self report questionarie that assesses bulimia nervosa symptomatology.The range of scores is 0-30. Higher scores mean higher bulimic sympthoms

Body Shape Questionnaire, BSQ-343 months

A self report questionarie that assesses eating disorder symptomatology. The score is ranging between 34-204 points. Higher scores point to an increased level of concern on body shape.

Eating Disorder Inventory, EDI3 months

A self report questionarie that assesses eating disorder symptomatology. The range of scores is 0-192. Higher scores mean higher eating disorders sympthoms

Secondary Outcome Measures
NameTimeMethod
Working alliance Inventory -short, WAIS.3 months

A self report questionarie that assesses bulimia nervosa symptomatology. Values range from 12 to 84. Hihger scores meaning higher therapeutic alliance.

Autism-Spectrum Quotient, AQ3 months

A self report questionarie that assesses autistic traits. The range of scores is 0 to 50. Higher scores mean higher autistic traits.

Rosenberg Self-Esteem Scale, RSE.3 months

A self report questionarie that assesses self steem. The scale ranges from 0-30. Higher scores mean higher self-esteem. The range scores is 0-60.

Quality of Life Enjoyment and Satisfaction Questionnaire, Q-LES-Q.3 months

A self report questionarie that assesses quality of life. The range of scores is 0-100. Higher scores mean higher quality of life.

Difficulties in Emotion Regulation Scale (DERS).3 months

A self report questionarie that assesses emotion regulation difficulties. The scale ranges from 28-40. H igher scores indicate more difficulty in emotion regulation.

State -Trait Anxiety Inventory, STAI.3 months

A self report questionarie that assesses anxiety. Higher scores mean higher anxiety.

Beck Depression Inventory, BDI-II3 months

A self report questionarie that assesses depressive symptoatology. The range of scores is 0-83. Higher scores mean higher depressive symptoms.

Trial Locations

Locations (1)

Hospital de la Santa Creu i Sant Pau

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath